Frontiers in Pharmacology | Pharmacoepidemiology

Original Research

Accepted on 10 Jan 2025

Exploring the Association Between Herbal Medicine Usage and Drug-Induced Liver Injury: Insights from a Nationwide Population-Based Cohort Study Using SCCS in South Korea

in Pharmacoepidemiology

Taehyun Yang
Juhee Ahn
Sungho Won
Sanghun Lee

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1498124

Original Research

Published on 10 Jan 2025

Overweight and glucose/lipid metabolism abnormality associated with SSRIs: a pharmacovigilance study based on the FDA adverse event reporting system

in Pharmacoepidemiology

Jinming Cao
Zhicong Chen
Yan Wang
Yunpeng Ma
Zhen Yang
Jian Cai
Zhijun Xiao
Feng Xu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1517546

277 views

Editorial

Published on 10 Jan 2025

Editorial: Biologic drugs in immune-mediated inflammatory diseases, validation, drug-utilization, effectiveness, regulation, costs, and safety in the real-world

in Pharmacoepidemiology

Irma Convertino
Luciane Cruz Lopes
Nicole Pratt
Ylenia Ingrasciotta
Marco Tuccori

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1542453

169 views

Original Research

Accepted on 09 Jan 2025

Data mining and safety analysis of voriconazole in patients with a hematological malignant tumor based on the FAERS database: differences between children and adults

in Pharmacoepidemiology

Hao Li
Jiang Manxue
Xiaona Pan
Lingti Kong

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1524702

Original Research

Published on 09 Jan 2025

Adverse drug events (ADEs) risk signal mining related to eculizumab based on the FARES database

in Pharmacoepidemiology

Xi-Feng Wang
Lu-Ri Bao
Ta-La Hu
Rui-Feng Xu
Wu-Niri Gao
Jing-Yuan Wang
Jian-Rong Zhao
Zhen-Li Fu
Yan Meng
Shu-Fang Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1440907

220 views

Original Research

Accepted on 08 Jan 2025

A post-marketing pharmacovigilance study of triazole antifungals:adverse event data mining and analysis based on the FDA Adverse Event Reporting System database

in Pharmacoepidemiology

Yalan Tian
Min Jin
Hong Ning

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1462510

Original Research

Published on 08 Jan 2025

Safety of combined drug use in patients with cardiovascular and cerebrovascular diseases: an analysis based on the spontaneous reporting database of adverse drug reactions in Hubei Province

in Pharmacoepidemiology

Jia Wang
Yuhang Zhao
Zherui Chen
Rui Huang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1451713

143 views

Systematic Review

Accepted on 07 Jan 2025

Global Bibliometric Analysis of Traditional Chinese Medicine Regulating Gut Microbiota in the Treatment of Diabetes from 2004 to 2024

in Pharmacoepidemiology

Jieling Liang
Xiaojuan Lin
Xin Liao
Xi Chen
Ying Zhou
Lin Zhang
Yunyun Qin
Haoru Meng
Zhongwen Feng

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1533984

Original Research

Published on 07 Jan 2025

Disproportionate adverse event signals of selumetinib in neurofibromatosis type I: insights from FAERS

in Pharmacoepidemiology

Lin Li

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1454418

255 views

Original Research

Published on 07 Jan 2025

Comprehensive analysis of adverse events associated with onasemnogene abeparvovec (Zolgensma) in spinal muscular atrophy patients: insights from FAERS database

in Pharmacoepidemiology

Wenwen Zhang
Yizhen Yin
Dan Yang
Mengyuan Liu
Caixia Ye
Ruiling Yan
Ruiman Li

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1475884

489 views

Original Research

Published on 06 Jan 2025

Drug-induced urinary retention: a real-world pharmacovigilance study using FDA and Canada vigilance databases

in Pharmacoepidemiology

Xianyu Dai
Kai Yu
Yu Chang
Yuchuan Hou

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1466875

221 views

Original Research

Published on 03 Jan 2025

Inappropriate prescribing of drugs for peptic ulcer and gastro-esophageal reflux disease remains a matter of concern: Results from the LAPTOP-PPI cluster randomized trial

in Pharmacoepidemiology

Manuela Casula
Ilaria Ardoino
Laura Pierini
Lara Perrella
Stefano Scotti
Sara Mucherino
Valentina Orlando
Enrica Menditto
Carlotta Franchi

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1430879

442 views

Original Research

Published on 23 Dec 2024

Safety assessment of deutetrabenazine: real-world adverse event analysis from the FAERS database

in Pharmacoepidemiology

Yanping Shu
Yuanhe Wang
Jiaoying Liu
Lingyan Hu
Sichao Tong
Gang Wu
Xianlin Zhu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1498215

588 views

Original Research

Published on 18 Dec 2024

Drug-induced coagulopathies: a real-world pharmacovigilance study using the FDA adverse event reporting system

in Pharmacoepidemiology

Yanjun Lu
Qian Xu
Shita Zhu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1486422

630 views

Original Research

Published on 17 Dec 2024

Anti-migraine medications safety during pregnancy in the US

in Pharmacoepidemiology

A. Bérard
S. Strom
D. Albrecht
S. Kori

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1481378

474 views

Original Research

Published on 17 Dec 2024

A real-world pharmacovigilance study of Sorafenib based on the FDA Adverse Event Reporting System

in Pharmacoepidemiology

Dongdong Zhang
Ying Cai
Yixin Sun
Peiji Zeng
Wei Wang
Wenhui Wang
Xiaohua Jiang
Yifan Lian

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1442765

809 views

Navigation group

Articles

Exploring the Association Between Herbal Medicine Usage and Drug-Induced Liver Injury: Insights from a Nationwide Population-Based Cohort Study Using SCCS in South Korea

Overweight and glucose/lipid metabolism abnormality associated with SSRIs: a pharmacovigilance study based on the FDA adverse event reporting system

Editorial: Biologic drugs in immune-mediated inflammatory diseases, validation, drug-utilization, effectiveness, regulation, costs, and safety in the real-world

Data mining and safety analysis of voriconazole in patients with a hematological malignant tumor based on the FAERS database: differences between children and adults

Adverse drug events (ADEs) risk signal mining related to eculizumab based on the FARES database

A post-marketing pharmacovigilance study of triazole antifungals:adverse event data mining and analysis based on the FDA Adverse Event Reporting System database

Safety of combined drug use in patients with cardiovascular and cerebrovascular diseases: an analysis based on the spontaneous reporting database of adverse drug reactions in Hubei Province

Global Bibliometric Analysis of Traditional Chinese Medicine Regulating Gut Microbiota in the Treatment of Diabetes from 2004 to 2024

Disproportionate adverse event signals of selumetinib in neurofibromatosis type I: insights from FAERS

Comprehensive analysis of adverse events associated with onasemnogene abeparvovec (Zolgensma) in spinal muscular atrophy patients: insights from FAERS database

Drug-induced urinary retention: a real-world pharmacovigilance study using FDA and Canada vigilance databases

Inappropriate prescribing of drugs for peptic ulcer and gastro-esophageal reflux disease remains a matter of concern: Results from the LAPTOP-PPI cluster randomized trial

Safety assessment of deutetrabenazine: real-world adverse event analysis from the FAERS database

Drug-induced coagulopathies: a real-world pharmacovigilance study using the FDA adverse event reporting system

Anti-migraine medications safety during pregnancy in the US

A real-world pharmacovigilance study of Sorafenib based on the FDA Adverse Event Reporting System